Currently, there are no manufacturers of blood products in Canada. However, both Green Cross Biotherapeutics and Therapure Biopharma are getting into the business. Within five years, CBS hopes to increase collection markedly to about 500,000 litres a year, with the use of dedicated plasma collection centres. But CBS has no plans to pay donors, other than the traditional cookies and juice. Nor does it plan to buy plasma from other providers, such as Canadian Plasma Resources.In fact, what Canadian Plasma Resources plans to do with the plasma it has collected is unclear as it does not have license from the U.S. Food and Drug Administration, which means it essentially can’t sell its plasma in the United States. What is clear, however, is that there is a lot of action in the blood business; as opportunities arise, we must be careful to not repeat the errors at the root of the tainted-blood debacle. What policy makers need to do now is come up with a clear, coherent position on issues such as paying for plasma and domestic production of blood products rather than grasping at every shiny bauble that comes along.